Dynamics of protein aggregation and oligomer formation governed by secondary nucleation.

The formation of aggregates in many protein systems can be significantly accelerated by secondary nucleation, a process where existing assemblies catalyse the nucleation of new species. In particular, secondary nucleation has emerged as a central process controlling the proliferation of many filamentous protein structures, including molecular species related to diseases such as sickle cell anemia and a range of neurodegenerative conditions. Increasing evidence suggests that the physical size of protein filaments plays a key role in determining their potential for deleterious interactions with living cells, with smaller aggregates of misfolded proteins, oligomers, being particularly toxic. It is thus crucial to progress towards an understanding of the factors that control the sizes of protein aggregates. However, the influence of secondary nucleation on the time evolution of aggregate size distributions has been challenging to quantify. This difficulty originates in large part from the fact that secondary nucleation couples the dynamics of species distant in size space. Here, we approach this problem by presenting an analytical treatment of the master equation describing the growth kinetics of linear protein structures proliferating through secondary nucleation and provide closed-form expressions for the temporal evolution of the resulting aggregate size distribution. We show how the availability of analytical solutions for the full filament distribution allows us to identify the key physical parameters that control the sizes of growing protein filaments. Furthermore, we use these results to probe the dynamics of the populations of small oligomeric species as they are formed through secondary nucleation and discuss the implications of our work for understanding the factors that promote or curtail the production of these species with a potentially high deleterious biological activity.

[1]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[2]  S. Rangarajan,et al.  On one-dimensional nucleation and growth of "living" polymers I. Homogeneous nucleation. , 1983, Journal of theoretical biology.

[3]  Holy,et al.  Microtubule dynamics: Caps, catastrophes, and coupled hydrolysis. , 1996, Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics.

[4]  Jozef Adamcik,et al.  Biodegradable nanocomposites of amyloid fibrils and graphene with shape-memory and enzyme-sensing properties. , 2012, Nature nanotechnology.

[5]  R. Mezzenga,et al.  Hybrid Nanocomposites of Gold Single‐Crystal Platelets and Amyloid Fibrils with Tunable Fluorescence, Conductivity, and Sensing Properties , 2013, Advanced materials.

[6]  Massimo Morbidelli,et al.  Population balance modeling of antibodies aggregation kinetics. , 2012, The journal of physical chemistry. B.

[7]  P. Lansbury,et al.  A century-old debate on protein aggregation and neurodegeneration enters the clinic , 2006, Nature.

[8]  S. Rangarajan,et al.  On one-dimensional nucleation and growth of "living" polymers. II. Growth at constant monomer concentration. , 1983, Journal of theoretical biology.

[9]  J. Engel,et al.  Kinetics of the cooperative association of actin to actin filaments. , 1975, Biophysical chemistry.

[10]  A. Miranker,et al.  Fiber-dependent amyloid formation as catalysis of an existing reaction pathway , 2007, Proceedings of the National Academy of Sciences.

[11]  T. Pollard,et al.  The Arp2/3 complex nucleates actin filament branches from the sides of pre-existing filaments , 2001, Nature Cell Biology.

[12]  W. Dauer,et al.  Parkinson's Disease Mechanisms and Models , 2003, Neuron.

[13]  Tuomas P. J. Knowles,et al.  An Analytical Solution to the Kinetics of Breakable Filament Assembly , 2009, Science.

[14]  F. Ferrone,et al.  The Double Nucleation Model for Sickle Cell Haemoglobin Polymerization: Full Integration and Comparison with Experimental Data , 2008, Acta biotheoretica.

[15]  S. Auer,et al.  Universality in the morphology and mechanics of coarsening amyloid fibril networks. , 2014, Physical review letters.

[16]  R. Pappu,et al.  Unmasking the roles of N- and C-terminal flanking sequences from exon 1 of huntingtin as modulators of polyglutamine aggregation , 2013, Proceedings of the National Academy of Sciences.

[17]  Markus J Buehler,et al.  Nanomechanics of functional and pathological amyloid materials. , 2011, Nature nanotechnology.

[18]  J. Hofrichter,et al.  Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism. , 1985, Journal of molecular biology.

[19]  B. Strooper,et al.  The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics , 2011, Nature Reviews Drug Discovery.

[20]  Jianing Zhang,et al.  Simulations of nucleation and elongation of amyloid fibrils. , 2009, The Journal of chemical physics.

[21]  F. Oosawa,et al.  A theory of linear and helical aggregations of macromolecules. , 1962, Journal of molecular biology.

[22]  E. Korn,et al.  The kinetics of actin nucleation and polymerization. , 1983, The Journal of biological chemistry.

[23]  C. Dobson,et al.  A kinetic study of β‐lactoglobulin amyloid fibril formation promoted by urea , 2002 .

[24]  C. Dobson Protein folding and misfolding , 2003, Nature.

[25]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. III. Equilibrium behavior and oligomer populations. , 2011, The Journal of chemical physics.

[26]  D. Frenkel,et al.  Onset of heterogeneous crystal nucleation in colloidal suspensions , 2004, Nature.

[27]  S. Radford,et al.  Systematic analysis of nucleation-dependent polymerization reveals new insights into the mechanism of amyloid self-assembly , 2008, Proceedings of the National Academy of Sciences.

[28]  T. Knowles,et al.  Kinetic theory of protein filament growth: Self-consistent methods and perturbative techniques , 2015 .

[29]  R. Pappu,et al.  Assessing the contribution of heterogeneous distributions of oligomers to aggregation mechanisms of polyglutamine peptides. , 2011, Biophysical chemistry.

[30]  S. Teichmann,et al.  The importance of sequence diversity in the aggregation and evolution of proteins , 2005, Nature.

[31]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[32]  T. Knowles,et al.  Asymptotic solutions of the Oosawa model for the length distribution of biofilaments. , 2014, The Journal of chemical physics.

[33]  T. L. Hill Length dependence of rate constants for end-to-end association and dissociation of equilibrium linear aggregates. , 1983, Biophysical journal.

[34]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. I. Time evolution of the principal moments. , 2011, The Journal of chemical physics.

[35]  V. Martorana,et al.  Branching in amyloid fibril growth. , 2009, Biophysical journal.

[36]  P E Fraser,et al.  A kinetic model for amyloid formation in the prion diseases: importance of seeding. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[37]  D. Selkoe Folding proteins in fatal ways , 2003, Nature.

[38]  J. Crassous,et al.  Quantifying the reversible association of thermosensitive nanoparticles. , 2011, Physical review letters.

[39]  Carl Frieden,et al.  Polymerization of actin and actin-like systems: evaluation of the time course of polymerization in relation to the mechanism. , 1983, Biochemistry.

[40]  F. Leyvraz,et al.  Scaling theory and exactly solved models in the kinetics of irreversible aggregation , 2003, cond-mat/0305670.

[41]  C. Dobson,et al.  Protein misfolding, functional amyloid, and human disease. , 2006, Annual review of biochemistry.

[42]  J. Crassous,et al.  Colloidal gelation with variable attraction energy. , 2013, The Journal of chemical physics.

[43]  M. Morbidelli,et al.  Time evolution of amyloid fibril length distribution described by a population balance model , 2012 .

[44]  E. Rhoades,et al.  Aggregation of an amyloidogenic fragment of human islet amyloid polypeptide. , 2000, Biochimica et biophysica acta.

[45]  F. Ferrone,et al.  Analysis of protein aggregation kinetics. , 1999, Methods in enzymology.

[46]  Ehud Gazit,et al.  Self-assembled peptide nanostructures: the design of molecular building blocks and their technological utilization. , 2007, Chemical Society reviews.

[47]  Christian Haass,et al.  Games Played by Rogue Proteins in Prion Disorders and Alzheimer's Disease , 2003, Science.

[48]  F. Ferrone,et al.  Kinetics of nucleation-controlled polymerization. A perturbation treatment for use with a secondary pathway. , 1984, Biophysical journal.

[49]  Michele Vendruscolo,et al.  The molecular chaperone Brichos breaks the catalytic cycle that generates toxic Aβ oligomers , 2015, Nature Structural &Molecular Biology.

[50]  D. Selkoe,et al.  Aβ Oligomers – a decade of discovery , 2007, Journal of neurochemistry.

[51]  Michele Vendruscolo,et al.  Chemical kinetics for drug discovery to combat protein aggregation diseases. , 2014, Trends in pharmacological sciences.

[52]  D. Henze,et al.  The role of amyloid-beta derived diffusible ligands (ADDLs) in Alzheimer's disease. , 2006, Current topics in medicinal chemistry.

[53]  Tuomas P. J. Knowles,et al.  Mean-field master equation formalism for biofilament growth , 2014 .

[54]  Michele Vendruscolo,et al.  Proliferation of amyloid-β42 aggregates occurs through a secondary nucleation mechanism , 2013, Proceedings of the National Academy of Sciences.

[55]  A. Donald,et al.  Electrostatics controls the formation of amyloid superstructures in protein aggregation. , 2013, Physical review letters.

[56]  Thomas C T Michaels,et al.  Role of filament annealing in the kinetics and thermodynamics of nucleated polymerization. , 2014, The Journal of chemical physics.

[57]  Tracy O'Connor,et al.  Protein aggregation diseases: pathogenicity and therapeutic perspectives , 2010, Nature Reviews Drug Discovery.

[58]  Michele Vendruscolo,et al.  Nucleated polymerization with secondary pathways. II. Determination of self-consistent solutions to growth processes described by non-linear master equations. , 2011, The Journal of chemical physics.